Clinical trial NCT00583765 - References

Kidney Failure, Acute — Evaluation of a Simplified Protocol for Regional Citrate Anticoagulation in Continuous Venovenous Hemodiafiltration

Citation(s)

•   Amanzadeh J, Reilly RF Jr
  Anticoagulation and continuous renal replacement therapy. Semin Dial. 2006 Jul-Aug;19(4):311-6. Review.
•   Bunchman TE, Maxvold NJ, Barnett J, Hutchings A, Benfield MR
  Pediatric hemofiltration: Normocarb dialysate solution with citrate anticoagulation. Pediatr Nephrol. 2002 Mar;17(3):150-4.
•   Bunchman TE, Maxvold NJ, Brophy PD
  Pediatric convective hemofiltration: Normocarb replacement fluid and citrate anticoagulation. Am J Kidney Dis. 2003 Dec;42(6):1248-52.
•   Fischer KG
  Essentials of anticoagulation in hemodialysis. Hemodial Int. 2007 Apr;11(2):178-89. Review.
•   Gabutti L, Ferrari N, Mombelli G, Keller F, Marone C
  The favorable effect of regional citrate anticoagulation on interleukin-1beta release is dissociated from both coagulation and complement activation. J Nephrol. 2004 Nov-Dec;17(6):819-25.
•   Gabutti L, Marone C, Colucci G, Duchini F, Schönholzer C
  Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challenge. Intensive Care Med. 2002 Oct;28(10):1419-25. Epub 2002 Sep 6.
•   Gibney RT, Kimmel PL, Lazarus M
  The Acute Dialysis Quality Initiative--part I: definitions and reporting of CRRT techniques. Adv Ren Replace Ther. 2002 Oct;9(4):252-4. Review.
•   Gibney RT, Stollery DE, Lefebvre RE, Sharun CJ, Chan P
  Continuous arteriovenous hemodialysis: an alternative therapy for acute renal failure associated with critical illness. CMAJ. 1988 Nov 1;139(9):861-6.
•   Gritters M, Grooteman MP, Schoorl M, Schoorl M, Bartels PC, Scheffer PG, Teerlink T, Schalkwijk CG, Spreeuwenberg M, Nubé MJ
  Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis. Nephrol Dial Transplant. 2006 Jan;21(1):153-9. Epub 2005 Sep 6.
•   Jacka MJ, Ivancinova X, Gibney RT
  Continuous renal replacement therapy improves renal recovery from acute renal failure. Can J Anaesth. 2005 Mar;52(3):327-32.
•   Kutsogiannis DJ, Gibney RT, Stollery D, Gao J
  Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Int. 2005 Jun;67(6):2361-7.
•   Kutsogiannis DJ, Mayers I, Chin WD, Gibney RT
  Regional citrate anticoagulation in continuous venovenous hemodiafiltration. Am J Kidney Dis. 2000 May;35(5):802-11.
•   Mariano F, Tetta C, Ronco C, Triolo G
  Is there a real alternative anticoagulant to heparin in continuous treatments? Expert Rev Med Devices. 2006 Jan;3(1):5-8.
•   Mariano F, Tetta C, Stella M, Biolino P, Miletto A, Triolo G
  Regional citrate anticoagulation in critically ill patients treated with plasma filtration and adsorption. Blood Purif. 2004;22(3):313-9.
•   Morath C, Miftari N, Dikow R, Hainer C, Zeier M, Morgera S, Weigand MA, Schwenger V
  Sodium citrate anticoagulation during sustained low efficiency dialysis (SLED) in patients with acute renal failure and severely impaired liver function. Nephrol Dial Transplant. 2008 Jan;23(1):421-2. Epub 2007 Oct 3.
•   Morgera S, Scholle C, Voss G, Haase M, Vargas-Hein O, Krausch D, Melzer C, Rosseau S, Zuckermann-Becker H, Neumayer HH
  Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: single-center experience. Nephron Clin Pract. 2004;97(4):c131-6.
•   Palsson R, Laliberte KA, Niles JL
  Choice of replacement solution and anticoagulant in continuous venovenous hemofiltration. Clin Nephrol. 2006 Jan;65(1):34-42.
•   Palsson R, Niles JL
  Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int. 1999 May;55(5):1991-7.
•   Swartz R, Pasko D, O'Toole J, Starmann B
  Improving the delivery of continuous renal replacement therapy using regional citrate anticoagulation. Clin Nephrol. 2004 Feb;61(2):134-43.
•   Tobe SW, Aujla P, Walele AA, Oliver MJ, Naimark DM, Perkins NJ, Beardsall M
  A novel regional citrate anticoagulation protocol for CRRT using only commercially available solutions. J Crit Care. 2003 Jun;18(2):121-9.
•   Tolwani AJ, Campbell RC, Schenk MB, Allon M, Warnock DG
  Simplified citrate anticoagulation for continuous renal replacement therapy. Kidney Int. 2001 Jul;60(1):370-4.
•   Tolwani AJ, Prendergast MB, Speer RR, Stofan BS, Wille KM
  A practical citrate anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance. Clin J Am Soc Nephrol. 2006 Jan;1(1):79-87. Epub 2005 Nov 23.
•   Uchino S, Bellomo R, Kellum JA, Morimatsu H, Morgera S, Schetz MR, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-Van Straaten HM, Ronco C; Beginning and Ending Supportive Therapy for the Kidney (B
  E.S.T. Kidney) Investigators Writing Committee. Patient and kidney survival by dialysis modality in critically ill patients with acute kidney injury. Int J Artif Organs. 2007 Apr;30(4):281-92.
•   Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C; Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators
  Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005 Aug 17;294(7):813-8.
•   Ward DM, Mehta RL
  Extracorporeal management of acute renal failure patients at high risk of bleeding. Kidney Int Suppl. 1993 Jun;41:S237-44.
•   Ward DM
  The approach to anticoagulation in patients treated with extracorporeal therapy in the intensive care unit. Adv Ren Replace Ther. 1997 Apr;4(2):160-73. Review.

Evaluation of a Simplified Protocol for Regional Citrate Anticoagulation in Continuous Venovenous Hemodiafiltration

Details for clinical trial NCT00583765